Panagora Asset Management Inc Arcus Biosciences, Inc. Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 112,829 shares of RCUS stock, worth $1.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

112,829

Previous 245,607 54.06%

Holding current value

$1.6 Million

Previous $3.74 Million 53.88%

% of portfolio

0.01%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$13.69 - $18.01 $1.82 Million - $2.39 Million	-132,778 Reduced 54.06%	112,829 $1.73 Million
Q2 2024 Jul 29, 2024	SELL	$14.59 - $18.48 $2.11 Million - $2.67 Million	-144,692 Reduced 37.07%	245,607 $3.74 Million
Q1 2024 May 07, 2024	BUY	$14.83 - $20.18 $2.39 Million - $3.26 Million	161,303 Added 70.44%	390,299 $7.37 Million
Q4 2023 Feb 08, 2024	BUY	$13.43 - $19.63 $1.74 Million - $2.55 Million	129,697 Added 130.61%	228,996 $4.37 Million
Q3 2023 Oct 31, 2023	BUY	$17.62 - $23.54 $37,125 - $49,598	2,107 Added 2.17%	99,299 $1.78 Million
Q2 2023 Aug 11, 2023	SELL	$16.97 - $22.03 $2.64 Million - $3.43 Million	-155,792 Reduced 61.58%	97,192 $1.97 Million
Q1 2023 May 11, 2023	BUY	$15.96 - $23.15 $883,928 - $1.28 Million	55,384 Added 28.03%	252,984 $4.61 Million
Q4 2022 Feb 13, 2023	BUY	$19.7 - $35.71 $265,280 - $480,870	13,466 Added 7.31%	197,600 $4.09 Million
Q3 2022 Nov 14, 2022	BUY	$23.23 - $30.07 $142,167 - $184,028	6,120 Added 3.44%	184,134 $4.82 Million
Q2 2022 Aug 15, 2022	BUY	$17.23 - $37.73 $236,240 - $517,316	13,711 Added 8.34%	178,014 $4.51 Million
Q1 2022 May 12, 2022	BUY	$28.92 - $41.83 $251,141 - $363,251	8,684 Added 5.58%	164,303 $5.19 Million
Q4 2021 Feb 10, 2022	SELL	$31.38 - $48.47 $958,941 - $1.48 Million	-30,559 Reduced 16.41%	155,619 $6.3 Million
Q3 2021 Nov 10, 2021	SELL	$26.93 - $37.68 $88,222 - $123,439	-3,276 Reduced 1.73%	186,178 $6.49 Million
Q2 2021 Aug 11, 2021	SELL	$22.75 - $35.77 $61,334 - $96,435	-2,696 Reduced 1.4%	189,454 $5.2 Million
Q1 2021 May 12, 2021	BUY	$26.16 - $41.39 $1.24 Million - $1.96 Million	47,363 Added 32.71%	192,150 $5.4 Million
Q4 2020 Feb 10, 2021	SELL	$17.0 - $32.36 $54,689 - $104,102	-3,217 Reduced 2.17%	144,787 $3.76 Million
Q3 2020 Nov 13, 2020	SELL	$17.14 - $25.47 $323,688 - $481,000	-18,885 Reduced 11.32%	148,004 $2.54 Million
Q2 2020 Aug 12, 2020	BUY	$13.97 - $36.56 $1.71 Million - $4.49 Million	122,703 Added 277.7%	166,889 $4.13 Million
Q1 2020 May 14, 2020	BUY	$8.78 - $19.28 $372,930 - $818,918	42,475 Added 2482.47%	44,186 $613,000
Q4 2019 Feb 12, 2020	BUY	$7.33 - $10.79 $2,580 - $3,798	352 Added 25.9%	1,711 $17,000
Q3 2019 Nov 12, 2019	SELL	$6.44 - $10.18 $431 - $682	-67 Reduced 4.7%	1,359 $12,000
Q2 2019 Aug 09, 2019	BUY	$7.29 - $13.38 $10,395 - $19,079	1,426 New	1,426 $11,000

Others Institutions Holding RCUS

# of Institutions

200

Shares Held

51.5M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.02B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Arcus Biosciences, Inc. Transaction History